Cabaletta Bio (CABA) Shareholder's Equity (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 112.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112.05 Mn |
| Sep 30, 2025 | 139.47 Mn |
| Jun 30, 2025 | 178.48 Mn |
| Mar 31, 2025 | 121.55 Mn |
| Dec 31, 2024 | 152.34 Mn |
| Sep 30, 2024 | 174.24 Mn |
| Jun 30, 2024 | 199.52 Mn |
| Mar 31, 2024 | 221.72 Mn |
| Dec 31, 2023 | 236.20 Mn |
| Sep 30, 2023 | 160.92 Mn |
| Jun 30, 2023 | 174.14 Mn |
| Mar 31, 2023 | 91.65 Mn |
| Dec 31, 2022 | 104.52 Mn |
| Sep 30, 2022 | 85.87 Mn |
| Jun 30, 2022 | 95.53 Mn |
| Mar 31, 2022 | 106.72 Mn |
| Dec 31, 2021 | 117.96 Mn |
| Sep 30, 2021 | 116.62 Mn |
| Jun 30, 2021 | 101.33 Mn |
| Mar 31, 2021 | 103.31 Mn |
| Dec 31, 2020 | 109.54 Mn |
| Sep 30, 2020 | 117.51 Mn |
| Jun 30, 2020 | 124.64 Mn |
| Mar 31, 2020 | 131.71 Mn |
| Dec 31, 2019 | 138.32 Mn |
| Sep 30, 2019 | -26.08 Mn |
| Jun 30, 2019 | -21.99 Mn |
| Mar 31, 2019 | -19.05 Mn |
| Dec 31, 2018 | -10.69 Mn |
| Sep 30, 2018 | -10.22 Mn |